We assessed the anti-inflammation and anti-allergic effect of stigmasterol in OVA-induced asthma mice and IL-13-induced BEAS-2B cells, and investigated if NK1R is the underlying target of stigmasterol in the treatment of asthma. This evidence concerns the gene TACR1 and asthma.